Recent Developments in Diagnosis and Assessment of Morphea

Overview

Journal Curr Rheumatol Rep

Publisher Current Science

Specialty Rheumatology

Date 2013 Jan 12

PMID 23307579

Citations 10

Authors

Sarah Nouri

Heidi Jacobe

Affiliations

Soon will be listed here.

Abstract

There is huge variation in the evaluation, diagnosis, and treatment of patients with morphea (localized scleroderma). In part, this variability results from the lack of validated methods to assess severity and outcomes with a consequent lack of adequate therapeutic trials. Evaluation is also hindered by lack of information regarding the impact of morphea on patients. Recent studies are addressing this gap in knowledge and include: development of clinical outcome measures, validation of imaging studies, publication of consensus treatment plans, and increased understanding of the impact of morphea on patients and parents. The purpose of this review is to summarize the results of these studies and to synthesize the information into a rational approach to the diagnosis and assessment of patients with morphea.

Citing Articles

High-frequency ultrasound evaluation of morphea: Retrospective analytical study.

Yazdanparast T, Mohseni A, Dehghan K, Delavar S, Firooz A Skin Res Technol. 2024; 30(7):e13818.

PMID: 38924131 PMC: 11197076. DOI: 10.1111/srt.13818.

Role of imaging in morphea assessment: A review of the literature.

Khorasanizadeh F, Kalantari Y, Etesami I Skin Res Technol. 2023; 29(7):e13410.

PMID: 37522502 PMC: 10318382. DOI: 10.1111/srt.13410.

Study about evaluation of efficacy of methotrexate in localized scleroderma using ultrasonography.

Zhang F, Li J, Zhao Q, Liu H, Zhang F Skin Res Technol. 2023; 29(3):e13300.

PMID: 36973989 PMC: 10155795. DOI: 10.1111/srt.13300.

Morphea: The 2023 update.

Papara C, De Luca D, Bieber K, Vorobyev A, Ludwig R Front Med (Lausanne). 2023; 10:1108623.

PMID: 36860340 PMC: 9969991. DOI: 10.3389/fmed.2023.1108623.

Controversy around the morphea.

Danczak-Pazdrowska A, Cieplewicz P, Zaba R, Adamski Z, Polanska A Postepy Dermatol Alergol. 2021; 38(5):716-720.

PMID: 34849114 PMC: 8610066. DOI: 10.5114/ada.2021.106242.

References

Ennis H, Herrick A, Baildam E, Richards H . Childrens' and parents' beliefs about childhood onset scleroderma are influenced by child age and physical function impairment. Rheumatology (Oxford). 2012; 51(7):1331-3. DOI: 10.1093/rheumatology/kes071. View

Skobieranda K, Helm K . Decreased expression of the human progenitor cell antigen (CD34) in morphea. Am J Dermatopathol. 1995; 17(5):471-5. DOI: 10.1097/00000372-199510000-00007. View

Arkachaisri T, Vilaiyuk S, Li S, ONeil K, Pope E, Higgins G . The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol. 2009; 36(12):2819-29. PMC: 3690503. DOI: 10.3899/jrheum.081284. View

Baildam E, Ennis H, Foster H, Shaw L, Chieng A, Kelly J . Influence of childhood scleroderma on physical function and quality of life. J Rheumatol. 2010; 38(1):167-73. DOI: 10.3899/jrheum.100447. View

Li S, Torok K, Pope E, Dedeoglu F, Hong S, Jacobe H . Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2012; 64(8):1175-85. PMC: 3724335. DOI: 10.1002/acr.21687. View

Weibel L, Laguda B, Atherton D, Harper J . Misdiagnosis and delay in referral of children with localized scleroderma. Br J Dermatol. 2011; 165(6):1308-13. DOI: 10.1111/j.1365-2133.2011.10600.x. View

Li S, Liebling M . The use of Doppler ultrasound to evaluate lesions of localized scleroderma. Curr Rheumatol Rep. 2009; 11(3):205-11. DOI: 10.1007/s11926-009-0028-y. View

Zulian F, Athreya B, Laxer R, Nelson A, Oliveira S, Punaro M . Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford). 2005; 45(5):614-20. DOI: 10.1093/rheumatology/kei251. View

Wortsman X, Wortsman J, Sazunic I, Carreno L . Activity assessment in morphea using color Doppler ultrasound. J Am Acad Dermatol. 2011; 65(5):942-8. DOI: 10.1016/j.jaad.2010.08.027. View

10.

Saxton-Daniels S, Jacobe H . An evaluation of long-term outcomes in adults with pediatric-onset morphea. Arch Dermatol. 2010; 146(9):1044-5. PMC: 2945300. DOI: 10.1001/archdermatol.2010.239. View

11.

Sherber N, Boin F, Hummers L, Wigley F . The "tank top sign": a unique pattern of skin fibrosis seen in pansclerotic morphea. Ann Rheum Dis. 2009; 68(9):1511-2. DOI: 10.1136/ard.2008.102723. View

12.

Arkachaisri T, Vilaiyuk S, Torok K, Medsger Jr T . Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford). 2009; 49(2):373-81. PMC: 3498950. DOI: 10.1093/rheumatology/kep361. View

13.

Li S, Liebling M, Ramji F, Opitz S, Mohanta A, Kornyat T . Sonographic evaluation of pediatric localized scleroderma: preliminary disease assessment measures. Pediatr Rheumatol Online J. 2010; 8:14. PMC: 2878299. DOI: 10.1186/1546-0096-8-14. View

14.

Lott J, Girardi M . Practice gaps. The hard task of measuring cutaneous fibrosis: comment on "14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma)". Arch Dermatol. 2011; 147(9):1115-6. DOI: 10.1001/archdermatol.2011.244. View

15.

Schanz S, Fierlbeck G, Ulmer A, Schmalzing M, Kummerle-Deschner J, Claussen C . Localized scleroderma: MR findings and clinical features. Radiology. 2011; 260(3):817-24. DOI: 10.1148/radiol.11102136. View

16.

McNiff J, Glusac E, Lazova R, Carroll C . Morphea limited to the superficial reticular dermis: an underrecognized histologic phenomenon. Am J Dermatopathol. 1999; 21(4):315-9. DOI: 10.1097/00000372-199908000-00001. View

17.

Stewart L, Nuara A, Anand D, Kia K, Cockerell C . Perifollicular papules and hyperkeratotic plaques on the back in a blaschkoid distribution. Morphea with features of lichen sclerosus et atrophicus (LS). Arch Dermatol. 2011; 147(7):857-62. DOI: 10.1001/archdermatol.2011.165-a. View

18.

Nezafati K, Cayce R, Susa J, Setiawan A, Tirkes T, Bendeck S . 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma). Arch Dermatol. 2011; 147(9):1112-5. DOI: 10.1001/archdermatol.2011.243. View

19.

Sung J, Chen T, Gilliam A, McCalmont T, Gilliam A . Clinicohistopathological correlations in juvenile localized scleroderma: studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes. J Am Acad Dermatol. 2011; 65(2):364-373. DOI: 10.1016/j.jaad.2010.02.065. View

20.

Horger M, Fierlbeck G, Kuemmerle-Deschner J, Tzaribachev N, Wehrmann M, Claussen C . MRI findings in deep and generalized morphea (localized scleroderma). AJR Am J Roentgenol. 2007; 190(1):32-9. DOI: 10.2214/AJR.07.2163. View